GB8524135D0 - Darodipine compositions - Google Patents

Darodipine compositions

Info

Publication number
GB8524135D0
GB8524135D0 GB858524135A GB8524135A GB8524135D0 GB 8524135 D0 GB8524135 D0 GB 8524135D0 GB 858524135 A GB858524135 A GB 858524135A GB 8524135 A GB8524135 A GB 8524135A GB 8524135 D0 GB8524135 D0 GB 8524135D0
Authority
GB
United Kingdom
Prior art keywords
darodipine
compositions
darodipine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858524135A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB858524135A priority Critical patent/GB8524135D0/en
Publication of GB8524135D0 publication Critical patent/GB8524135D0/en
Priority to NL8602370A priority patent/NL194822C/en
Priority to HU864004A priority patent/HU197201B/en
Priority to CH3780/86A priority patent/CH669524A5/de
Priority to DE3632201A priority patent/DE3632201C2/en
Priority to IE256586A priority patent/IE59589B1/en
Priority to DK464686A priority patent/DK170016B1/en
Priority to CA000519302A priority patent/CA1298784C/en
Priority to KR1019860008136A priority patent/KR920008817B1/en
Priority to IL80182A priority patent/IL80182A/en
Priority to NZ217732A priority patent/NZ217732A/en
Priority to AU63226/86A priority patent/AU598751B2/en
Priority to GB8623389A priority patent/GB2181053B/en
Priority to SE8604112A priority patent/SE503222C2/en
Priority to GR862457A priority patent/GR862457B/en
Priority to PT83456A priority patent/PT83456B/en
Priority to AT0260486A priority patent/AT402257B/en
Priority to BE1/011554A priority patent/BE905516A/en
Priority to LU86615A priority patent/LU86615A1/en
Priority to ES8602313A priority patent/ES2002508A6/en
Priority to IT8648494A priority patent/IT1214719B/en
Priority to JP23424986A priority patent/JPS62149618A/en
Priority to FR868613668A priority patent/FR2589732B1/en
Priority to ZA877507A priority patent/ZA867507B/en
Priority to AU53020/90A priority patent/AU626404B2/en
Priority to SG1033/91A priority patent/SG103391G/en
Priority to HK3/92A priority patent/HK392A/en
Priority to MX9203614A priority patent/MX9203614A/en
Priority to CY1622A priority patent/CY1622A/en
Pending legal-status Critical Current

Links

GB858524135A 1985-02-07 1985-10-01 Darodipine compositions Pending GB8524135D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
NL8602370A NL194822C (en) 1985-10-01 1986-09-19 Preparation for oral administration with controlled release and method for its preparation.
HU864004A HU197201B (en) 1985-10-01 1986-09-19 Process for producing oral pharmaceutical compositions of controlled solubility of the active components
CH3780/86A CH669524A5 (en) 1985-10-01 1986-09-22
DE3632201A DE3632201C2 (en) 1985-10-01 1986-09-23 Pharmaceutical composition with sustained release of the active substance
PT83456A PT83456B (en) 1985-10-01 1986-09-29 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE
GR862457A GR862457B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
DK464686A DK170016B1 (en) 1985-10-01 1986-09-29 Composition with controlled release of the active substance
CA000519302A CA1298784C (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
KR1019860008136A KR920008817B1 (en) 1985-10-01 1986-09-29 Process for the preparing pharmaceutical formulations with controlled release of the active substance
IL80182A IL80182A (en) 1985-10-01 1986-09-29 Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance
NZ217732A NZ217732A (en) 1985-10-01 1986-09-29 Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
AU63226/86A AU598751B2 (en) 1985-02-07 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
GB8623389A GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
SE8604112A SE503222C2 (en) 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine
IE256586A IE59589B1 (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
BE1/011554A BE905516A (en) 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION.
LU86615A LU86615A1 (en) 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION
JP23424986A JPS62149618A (en) 1985-10-01 1986-09-30 Active substance release control medicine
AT0260486A AT402257B (en) 1985-10-01 1986-09-30 METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF A 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER ACTIVE SUBSTANCE
ES8602313A ES2002508A6 (en) 1985-10-01 1986-09-30 New sustained-release formulation based on pindolol
IT8648494A IT1214719B (en) 1985-10-01 1986-09-30 Controlled release cardiovascular preparations
FR868613668A FR2589732B1 (en) 1985-10-01 1986-10-01 NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL
ZA877507A ZA867507B (en) 1985-10-01 1986-10-01 Pharmaceutical formulations with controlled release of the active substance
AU53020/90A AU626404B2 (en) 1985-10-01 1990-04-09 A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
SG1033/91A SG103391G (en) 1985-10-01 1991-12-04 Pharmaceutical formulations with controlled release of the active substance
HK3/92A HK392A (en) 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance
MX9203614A MX9203614A (en) 1985-10-01 1992-06-26 PHARMACEUTICAL FORMULATION OF CONTROLLED RELEASE FOR ORAL ADMINISTRATION.
CY1622A CY1622A (en) 1985-10-01 1992-07-10 Pharmaceutical formulations with controlled release of the active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions

Publications (1)

Publication Number Publication Date
GB8524135D0 true GB8524135D0 (en) 1985-11-06

Family

ID=10585981

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858524135A Pending GB8524135D0 (en) 1985-02-07 1985-10-01 Darodipine compositions

Country Status (4)

Country Link
JP (1) JPS62149618A (en)
AU (1) AU626404B2 (en)
GB (1) GB8524135D0 (en)
ZA (1) ZA867507B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3045135A1 (en) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
IT1174779B (en) * 1982-09-27 1987-07-01 Sandoz Ag THERAPEUTIC USE OF 1,4-DI HYDROPYRIDINE DERIVATIVES
JPS60202912A (en) * 1984-03-28 1985-10-14 Hitachi Metals Ltd Manufacture of anisotropic magnet roll

Also Published As

Publication number Publication date
JPS62149618A (en) 1987-07-03
AU5302090A (en) 1990-08-09
AU626404B2 (en) 1992-07-30
ZA867507B (en) 1988-05-25

Similar Documents

Publication Publication Date Title
IL78934A (en) Alfuzosine compositions
GB8514052D0 (en) Compositions
MW5186A1 (en) Compositions
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8509409D0 (en) Compositions
GB2171600B (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
GR860123B (en) Compositions
EP0192630A3 (en) Aminomethylenephosphonate compositions
GB2182561B (en) Pharmaceutical compositions
GB8513550D0 (en) Compositions
EP0225309A3 (en) Aminomethylenephosphonate compositions
GB8520289D0 (en) Compositions
ZA86355B (en) Compositions
GB8603048D0 (en) Lymphokine-containing compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8524135D0 (en) Darodipine compositions
EG17458A (en) Fungicial compositions
GB8514860D0 (en) Compositions
GB8518581D0 (en) Compositions
GB8527416D0 (en) Compositions
GB8617065D0 (en) Compositions
GB8527406D0 (en) Compositions
GB8526500D0 (en) Compositions
GB8526499D0 (en) Compositions